tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
Want to see RPRX full AI Analyst Report?

Compare Royalty Pharma (RPRX) vs. Competitors

1,302 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Royalty Pharma
$50.00
$29.99B
17.56
53.02%
7 Buy
0 Hold
0 Sell
Strong Buy
Incyte
$97.82
$19.02B
15.46
49.82%
8 Buy
8 Hold
1 Sell
Moderate Buy
United Therapeutics
$588.38
$24.07B
23.46
85.65%
11 Buy
3 Hold
0 Sell
Strong Buy
Ascendis Pharma
$244.48
$14.82B
4.77
48.43%
12 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$28.55
$15.67B
77.40
27.25%
7 Buy
2 Hold
0 Sell
Strong Buy
BioNTech SE
$102.92
$22.47B
-8.99
-10.24%
14 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RPRX
Royalty Pharma
52.41
20.27
63.07%
INCY
Incyte
95.60
30.82
47.58%
UTHR
United Therapeutics
566.80
257.12
83.03%
ASND
Ascendis Pharma
237.98
79.88
50.52%
GMAB
Genmab
25.68
5.16
25.15%
BNTX
BioNTech SE
87.79
-11.30
-11.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts